Walmart to replace Astrazeneca on Nasdaq-100

Jan 9 (Reuters) – Nasdaq ‍on Friday ‌said ‌U.S. retailer Walmart will replace British ​drugmaker ‍Astrazeneca ​in ​the ‍Nasdaq-100 Index effective on ‍January 20, 2026.

(Reporting ‍by ‍Rhea ​Rose ​Abraham ⁠in ‌Bengaluru; Editing by Tom ⁠Hogue)